However, when used in conjunction with anti-PD1 therapy, the combination was significantly more effective at controlling tumor growth than anti-PD1 treatment alone; indeed, four of five mice showed no evidence of remaining tumor. The gene discussed is PDCD1; the disease is neoplasm.